Aleva Neurotherapeutics raised €5.8M in a Series B round in May 2014. The company is based in Lausanne, Switzerland. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
